Nuveen Dow 30 Dynamic Overwrite Fund is a buy-write CEF that aims to replicate the Dow Jones index. The fund's complex risk factor, the SPY/DIA basis, has hindered its performance and is not properly disclosed. Retail investors would be better off buying DIA outright and writing their own call options rather than investing in DIAX.
Nuveen Dow 30 Dynamic Overwrite Fund aims to provide attractive total returns with less volatility than the Dow Jones Industrial Average. DIAX has delivered below market returns historically but has failed to deliver below market volatility. The Fund trades at a significant discount to NAV, but the dynamic nature of options exposure makes it a difficult arbitrage play.
Selling calls on long positions provides downside protection and shelters investors from stock volatility. The Nuveen Dow 30 Dynamic Overwrite Fund writes covered calls on a portion of its equity portfolio to reduce volatility. We examine whether this 8% yielding fund meets our buying criteria.
Nuveen Dow 30 Dynamic Overwrite Fund (DIAX) is trading at a larger discount compared to its historical level, potentially indicating an attractive opportunity. The fund aims to offer regular distributions with less volatility than the Dow Jones Industrial Average (DJIA) by investing in an equity portfolio and selling call options. However, the fund's odd positioning of writing index calls on indexes that they aren't replicating in their underlying portfolio presents a potential risk.
DIAX is an equity "buy-write" closed-end fund from Nuveen. The fund aims to replicate the Dow Jones Index through its portfolio composition and then write call options on the underlying names.